Advertisement
UK markets close in 6 hours 8 minutes
  • FTSE 100

    8,297.14
    +83.65 (+1.02%)
     
  • FTSE 250

    20,381.66
    +217.12 (+1.08%)
     
  • AIM

    776.82
    +5.29 (+0.69%)
     
  • GBP/EUR

    1.1653
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.2541
    -0.0023 (-0.18%)
     
  • Bitcoin GBP

    51,232.38
    -852.10 (-1.64%)
     
  • CMC Crypto 200

    1,332.00
    -33.12 (-2.43%)
     
  • S&P 500

    5,180.74
    +52.95 (+1.03%)
     
  • DOW

    38,852.27
    +176.59 (+0.46%)
     
  • CRUDE OIL

    78.66
    +0.18 (+0.23%)
     
  • GOLD FUTURES

    2,323.80
    -7.40 (-0.32%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     
  • DAX

    18,288.83
    +113.62 (+0.63%)
     
  • CAC 40

    8,026.44
    +29.80 (+0.37%)
     

Here's Why Altimmune Stock Is Surging Today

Here's Why Altimmune Stock Is Surging Today

Shares of Altimmune (NASDAQ: ALT), a clinical-stage biopharmaceutical company, are on the move following a positive clinical readout. Investors excited about the company's potential new weight loss drug drove the stock 23% higher as of 12:34 p.m. on Wednesday. Altimmune's weight loss drug candidate, ALT-801, is a GLP-1 receptor agonist that also activates glucagon receptors.